The purpose of this prospective , multicenter , randomized , controlled trial was to compare 2-year clinical outcomes in patients with moderate LSS treated with the Superion ( ) ( Experimental ) or the X-Stop ( ) , a FDA-approved interspinous spacer ( Control ) .